Skip to main content
Premium Trial:

Request an Annual Quote

nRichDx: Revolution System

nRichDx has launched its high-yield sample prep Revolution System. The Irvine, California firm designed the in vitro diagnostic system to increase liquid biopsy-based test sensitivity by delivering more target input for molecular assays. Researchers can currently use the platform to extract cell-free DNA from plasma and urine, followed by eventual applications for circulating tumor cells, exosomes, and total cell-free nucleic acid in the development pipeline. 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.